[ET Net News Agency, 29 January 2024] REMEGEN (09995) fell 5.4% to HK$18.3.
It hits an intra-day low of HK$18.3, hitting a historical low, and an intra-day high of
HK$20.2. The total shares traded was 2.92 million, with a value of HK$55.84m. The active
buy/sell ratio is 42:58, with net selling turnover of HK$8.5m. BARCLAYS CAPITAL ASIA
accounts for greatest net responsive buying turnover of HK$3.15m, with volume weighted
average price of HK$19.098. MERRILL LYNCH FE accounts for greatest net responsive selling
turnover of HK$6.28m, with volume weighted average price of HK$19.082. The stock has
fallen a combined 15.1% over the past 3 consecutive trading days.
Basic Information
=================
----------------------------------
Nominal 18.300 % Chg -5.38%
High 20.200 Low 18.300
Shares Tr 2.92m Turnover 55.84m
10-D SMA 22.849 %H.V 119.636
20-D SMA 28.229 VWAP 19.141
50-D SMA 35.346 RSI14 22.211
----------------------------------
Status: Hitting a historical low, active buy/sell ratio is 42:58, with net selling
turnover of HK$8.5m, falling a combined 15.1% over the past 3 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
REMEGEN (09995) 18.30 -5.38
HUTCHMED (00013) 20.25 -1.70
GENSCRIPT BIO (01548) 13.94 -3.46
INNOVENT BIO (01801) 33.45 +0.30
LAEKNA-B (02105) 5.23 -33.38
WUXI XDC (02268) 25.00 -0.79
WUXI BIO (02269) 23.05 -6.11
TIGERMED (03347) 26.35 -1.50
BEIGENE (06160) 95.60 +1.27
AKESO (09926) 40.65 -2.87
---------------------------------------------
(ed)